Search Within

Angela Rose Brannon

Formats
  1. Meeting Abstract (56)
  2. Journal Article (40)
  3. Research Letter (3)
Groups
  1. Department of Pathology and Laboratory Medicine (99)
  2. GSK Faculty (92)
  3. Human Oncology and Pathogenesis Program (92)
  4. Center for Molecular Imaging and Biotechnology (CMIB) (82)
  5. Department of Medicine (64)
  6. Solid Tumor Oncology Division (57)

More Groups

People
  1. Michael Berger (78)
  2. Marc Ladanyi (43)
  3. Maria Arcila (42)
  4. David Solit (30)
  5. Nikolaus Schultz (26)
  6. Ahmet Zehir (24)

More People

Years
  1. 2025 (5)
  2. 2024 (21)
  3. 2023 (15)
  4. 2022 (14)
  5. 2021 (5)
  6. 2020 (5)

More Years

Publications
  1. Journal of Clinical Oncology (16)
  2. Journal of Molecular Diagnostics (10)
  3. Cancer Research (8)
  4. Modern Pathology (7)
  5. Clinical Cancer Research (6)
  6. Laboratory Investigation (6)

More Publications

Publishers
  1. American Association for Cancer Research (19)
  2. American Society of Clinical Oncology (16)
  3. Nature Publishing Group (16)
  4. Elsevier Science, Inc. (12)
  5. Nature Research (7)
  6. Oxford University Press (7)

More Publishers

Results (99)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Hereditary leiomyomatosis and renal cell carcinoma (HLRCC)-associated renal cancer: The utility of detecting aberrant succination by immunohistochemistry
    Meeting Abstract

    Chen, Y. B.; Brannon, A. R.; Dudas, M. E.; Won, H.; Al-Ahmadie, H. A.; Fine, S. W.; Gopalan, A.; Frizzell, N.; Russo, P.; Berger, M. F.; more...
    Modern Pathology (2014)

    Fulltext@MSK | Save
  • ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma
    Journal Article

    Brooks, S. A.; Brannon, A. R.; Parker, J. S.; Fisher, J. C.; Sen, O.; Kattan, M. W.; Hakimi, A. A.; Hsieh, J. J.; Choueiri, T. K.; Tamboli, P.; more...
    European Urology (2014)

    Fulltext@MSK | Save
  • Tumor genetic analyses of patients with metastatic renal cell carcinoma and extended benefit from mTOR inhibitor therapy
    Journal Article

    Voss, M. H.; Hakimi, A. A.; Pham, C. G.; Brannon, A. R.; Chen, Y. B.; Cunha, L. F.; Akin, O.; Liu, H.; Takeda, S.; Scott, S. N.; more...
    Clinical Cancer Research (2014)

    Fulltext@MSK | Save
  • Hereditary leiomyomatosis and renal cell carcinoma syndrome-associated renal cancer: Recognition of the syndrome by pathologic features and the utility of detecting aberrant succination by immunohistochemistry
    Journal Article

    Chen, Y. B.; Brannon, A. R.; Toubaji, A.; Dudas, M. E.; Won, H. H.; Al-Ahmadie, H. A.; Fine, S. W.; Gopalan, A.; Frizzell, N.; Voss, M. H.; more...
    American Journal of Surgical Pathology (2014)

    Fulltext@MSK | Save
  • Next generation sequencing in effusion fluids from patients with ovarian serous carcinoma. A comparison with TCGA findings
    Meeting Abstract

    Lin, O.; Brannon, A. R.; Levine, D. A.; Arcila, M. E.; Scott, S. N.; Edelweiss, M.; Berger, M. F.
    Laboratory Investigation (2014)

    Fulltext@MSK | Save
  • mTOR pathway activation characterizes a subset of unclassified renal cell carcinoma: Immunohistochemical, molecular and histologic analysis
    Meeting Abstract

    Kong, M. X.; Brannon, A. R. R.; Won, H.; Gandhi, A.; Al-Ahmadie, H. A.; Fine, S. W.; Gopalan, A.; Russo, P.; Berger, M. F.; Tickoo, S. K.; more...
    Laboratory Investigation (2014)

    Fulltext@MSK | Save
  • Hereditary leiomyomatosis and renal cell carcinoma (HLRCC)-associated renal cancer: The utility of detecting aberrant succination by immunohistochemistry
    Meeting Abstract

    Chen, Y. B.; Brannon, A. R.; Dudas, M. E.; Won, H.; Al-Ahmadie, H. A.; Fine, S. W.; Gopalan, A.; Frizzell, N.; Russo, P.; Berger, M. F.; more...
    Laboratory Investigation (2014)

    Fulltext@MSK | Save
  • Effective monotherapy despite intratumor heterogeneity: Clonal convergence within the PI3K pathway and sensitivity to mTOR inhibitors in patients with advanced renal cell carcinoma (RCC)
    Meeting Abstract

    Voss, M. H.; Hakimi, A. A.; Chen, Y.; Pham, C. G.; Brannon, A. R.; Scott, S. N.; Takeda, S.; Liu, H.; Motzer, R. J.; Berger, M. F.; more...
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • A validated 34-gene signature for assessing risk of recurrence in clear cell renal cell carcinoma
    Meeting Abstract

    Rathmell, K.; Brooks, S. A.; Brannon, A. R.; Parker, J. S.; Fisher, J. C.; Sen, O.; Nielsen, M. E.
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • Delineating genomic heterogeneity in paired primary and metastatic colorectal cancer by massively parallel sequencing
    Meeting Abstract

    Brannon, A. R.; Vakiani, E.; Scott, S. N.; Sylvester, B.; Kania, K.; Viale, A.; Kemeny, N.; Weiser, M.; Solit, D. B.; Berger, M. F.
    Cancer Research (2013)

    Fulltext@MSK | Save